Accueil > Actualité
Actualite financiere : Actualite bourse

Bayer: reduced dose gadobutrol effective in MRI

( - Bayer today published the results of a Phase IV study showing the clinical efficacy of a reduced dose of gadobutrol, compared to a standard dose of gadoterate, in patients undergoing steady-state contrast MRI of the central nervous system.

As such, the total number of lesions detected per average reading was 301 for gadobutrol, versus 291 for gadoterate.

The study's data were presented at this year's European Society of Neuroradiology (ESNR) hybrid annual meeting, which is being held in Geneva until 3 October 2021.

Copyright (c) 2021 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.